(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE
生物活性靶点体内研究 用途与合成方法 MSDS (Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE价格(试剂级) 上下游产品信息
中文名称 | (Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE |
---|---|
中文同义词 | |
英文名称 | (Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE |
英文同义词 | (Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE;LORECLEZOLE HYDROCHLORIDE;R 72063 hydrochloride |
CAS号 | 2227372-56-5 |
分子式 | C10H7Cl4N3 |
分子量 | 310.99 |
EINECS号 | |
相关类别 | |
Mol文件 | Mol File |
结构式 |
(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE 性质
溶解度 | 在 DMSO 中温和加热时溶解度为 5 mM,在乙醇中温和加热时溶解度为 5 mM |
---|
Loreclezole hydrochloride 是一种抗癫痫化合物,是选择性的 GABAA 受体 的调节剂,是β2 或β3亚单位包含受体的正向变构调节剂。
GABA A receptor.
Loreclezole (10, 25, 50 or 75 mg/kg, i.p. 60 min before measurement of seizure threshold ) results in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. Loreclezole also has the least effect on loss of muscle tone as measured by the “pull-up” test.
Animal Model: | Adult male Lister Hooded rats. |
Dosage: | 10, 25, 50 or 75 mg/kg. |
Administration: | IP, 60 min before measurement of seizure threshold. |
Result: | Resulted in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. |